A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease
Clinical trial NCT03653247 · COMPLETED
Trial details
- NCT number
- NCT03653247
- Sponsor
- Sangamo Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-06
- Primary completion
- 2025-07-17
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.